Oral Science Protocol
Optimal Clinical Outcomes For Periodontal And Implant Health
Developed in Collaboration with Dr. Samuel B. Low, D.D.S., M.S., M.Ed., Dip AB Perio & Martha Szczepulski, BDSc(DH), DHP, PID
Dr. Samuel B. Low
D.D.S., M.S., M.Ed., Dip AB Perio
Renowned Periodontist, Educator, and Thought Leader.
Martha Szczepulski
BDSc(DH), DHP, PID
Professional Education Leader at Oral Science
We Can Help You for Periodontal Disease
Achieving and maintaining periodontal and peri-implant health is essential for long-term clinical success.
This program, developed in collaboration with Dr. Sam Low, renowned periodontist, educator, and thought leader, offers evidence-based strategies and advanced protocols designed to enhance patient outcomes.
We Can Help You for Peri-Imlant Disease
By integrating the latest in biofilm management and non-surgical therapies, clinicians can elevate the standard of care and achieve predictable, minimally invasive results. Whether for prevention, maintenance or intervention, this approach supports optimal tissue healing, improved patient comfort, and long-term success in both periodontal and implant cases.
1. Diagnostics & Monitoring
PerioMonitor
Result Assessment
2. In-Office Treatment
Biofilm And Calculus Management*
Woodpecker PT-B
Non-Antibiotic Periodontal Adjunct HybenX
3. Home-Care Treatment
Home-Care Recommendations* With Optional Dry Mouth Support
4 Week Re-eval.
Recall Interval (Months)
For Patients With Natural Dentition
| PerioMonitor Result | Assessment Results | Biofilm And Calculus Management* | Non Antibiotic Periodontal Adjunct HybenX | Home Care Recommendations* With Optional Dry Mouth Support | 4 Week Re-eval. | Recall Interval (Months) |
|---|---|---|---|---|---|---|
| Negative | PD ≤ 3mm 0% BOP | Yes | No | Curaprox: Daily Brushing & Interdental Care | No | 6 |
| Low | PD ≥ 3mm <10% BOP | Yes | No | Curaprox: Daily Brushing & Interdental Care | No | 4 |
| Moderate | PD ≥ 4mm >10% BOP Evidence of bone loss and/or suppuration | Yes | Yes | Curaprox: Daily Brushing & Interdental Care X-PUR Opti-Rinse: Targeted Antimicrobial Treatment | Yes | 3 |
| High | PD ≥ 5mm >10% BOP Evidence of bone loss and/or suppuration | Yes | Yes | Curaprox: Daily Brushing & Interdental Care X-PUR Opti-Rinse: Targeted Antimicrobial Treatment | Yes | 2-3 |
For Patients With Implants
| PerioMonitor Result | Assessment Results | Biofilm And Calculus Management* | Non-Antibiotic Periodontal Adjunct HybenX | Home-Care Recommendations* With Optional Dry Mouth Support | 4 Week Re-eval. | Recall Interval (Months) |
|---|---|---|---|---|---|---|
| Negative | PD ≤ 3mm 0% BOP | Yes | No | Curaprox: Daily Brushing & Interdental Care | No | 6+ |
| Low | PD ≥ 3mm <10% BOP | Yes | No | Curaprox: Daily Brushing & Interdental Care | No | 6 |
| Moderate | PD ≥ 4mm >10% BOP Evidence of Bone Loss | Yes | Yes | Curaprox: Daily Brushing & Interdental Care X-PUR Opti-Rinse: Targeted Antimicrobial Treatment | Yes | 3-4 |
| High | PD ≥ 5mm > 10% BOP Evidence of Bone Loss | Yes | Yes | Curaprox: Daily Brushing & Interdental Care X-PUR Opti-Rinse: Targeted Antimicrobial Treatment | Yes | 3 |
Optimal Clinical Outcomes For Periodontal And Implant Health
For patients with sensitivity, high caries risk or dry mouth, additional products may be required to achieve periodontal wellness.
Optimal Clinical Outcomes For Periodontal And Implant Health
Diagnostics, In-Office Treatment And Home-Care Treatment
Protocol Products
Products Referenced In The Protocol
Optimal Clinical Outcomes For Periodontal And Implant Health
This protocol is intended to serve as a general guideline and does not encompass all possible clinical scenarios. Clinicians are advised to use their professional judgment and consider individual patient circumstances when making clinical decisions.
